207 related articles for article (PubMed ID: 19534731)
1. The basics of preclinical drug development for neurodegenerative disease indications.
Steinmetz KL; Spack EG
BMC Neurol; 2009 Jun; 9 Suppl 1(Suppl 1):S2. PubMed ID: 19534731
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. Product Development within the National Institutes of Health Radiation and Nuclear Countermeasures Program.
Cassatt DR; DiCarlo AL; Molinar-Inglis O
Radiat Res; 2024 May; 201(5):471-478. PubMed ID: 38407357
[TBL] [Abstract][Full Text] [Related]
4. FDA requirements for nonclinical testing of contraceptive steroids.
Jordan A
Contraception; 1992 Dec; 46(6):499-509. PubMed ID: 1493710
[TBL] [Abstract][Full Text] [Related]
5. Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs.
Puthumana J; Miller JE; Kim J; Ross JS
JAMA Netw Open; 2018 Jun; 1(2):e180283. PubMed ID: 30646072
[TBL] [Abstract][Full Text] [Related]
6. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
7. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
8. Safety assessment of biotechnology-derived pharmaceuticals: ICH and beyond.
Serabian MA; Pilaro AM
Toxicol Pathol; 1999; 27(1):27-31. PubMed ID: 10367669
[TBL] [Abstract][Full Text] [Related]
9. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
[TBL] [Abstract][Full Text] [Related]
10. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
11. Repackaging FDA-approved drugs for degenerative diseases: promises and challenges.
Cummings JL; Zhong K
Expert Rev Clin Pharmacol; 2014 Mar; 7(2):161-5. PubMed ID: 24502586
[TBL] [Abstract][Full Text] [Related]
12. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
[TBL] [Abstract][Full Text] [Related]
13. Use of toxicological information in drug design.
Matthews EJ; Benz RD; Contrera JF
J Mol Graph Model; 2000 Dec; 18(6):605-15. PubMed ID: 11155316
[TBL] [Abstract][Full Text] [Related]
14. Drug Development 101: A Primer.
Buckley LA; Bebenek I; Cornwell PD; Hodowanec A; Jensen EC; Murphy C; Ghantous HN
Int J Toxicol; 2020; 39(5):379-396. PubMed ID: 32762387
[TBL] [Abstract][Full Text] [Related]
15. Regulatory decision strategy for entry of a novel biological therapeutic with a clinically unmonitorable toxicity into clinical trials: pre-IND meetings and a case example.
Black LE; Bendele AM; Bendele RA; Zack PM; Hamilton M
Toxicol Pathol; 1999; 27(1):22-6. PubMed ID: 10367668
[TBL] [Abstract][Full Text] [Related]
16. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.
Harapanhalli RS
Semin Nucl Med; 2010 Sep; 40(5):364-84. PubMed ID: 20674596
[TBL] [Abstract][Full Text] [Related]
17. Guidelines and requirements for the evaluation of contraceptive steroids.
McKenzie BE
Toxicol Pathol; 1989; 17(2):377-84. PubMed ID: 2675288
[TBL] [Abstract][Full Text] [Related]
18. Preclinical development strategies for novel gene therapeutic products.
Pilaro AM; Serabian MA
Toxicol Pathol; 1999; 27(1):4-7. PubMed ID: 10367665
[TBL] [Abstract][Full Text] [Related]
19. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease.
Hanson LR; Frey WH
BMC Neurosci; 2008 Dec; 9 Suppl 3(Suppl 3):S5. PubMed ID: 19091002
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
